Jiqin Lian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiqin Lian has a total of 188 co-authors. Here are the top co-authors by number of shared publications:
- Zhenhong Ni
State Key Laboratory of Trauma, Burns and Combined Injury, Department of Rehabilitation Medicine, Daping Hospital, Army Medical University, Chongqing, China
26 shared publications - Fengtian He
Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Army Medical University, Chongqing, China
25 shared publications - Yaran Wu
Department of Clinical Biochemistry, Faculty of Pharmacy and Laboratory Medicine, Army Medical University, Chongqing, China
17 shared publications Xufang Dai
Department of Educational College, Chongqing Normal University, Chongqing, China
16 shared publications- Xufang Dai
College of Education and Science, Chongqing Normal University, Chongqing, China
16 shared publications - Haojun Xiong
Key Laboratory of Hepatobiliary and Pancreatic Surgery, Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China
14 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Springer Nature in Cell Death Discovery
SIRT2-mediated deacetylation of ANT3 at Lys96 promotes cell death
ANT3 is a key molecule that constitutes the mitochondrial permeability transition pore (mPTP) and mediates cell death. Disruption or conformational changes in ANT3 protein homeostasis can trigger cell death. However, the molecular mechanism of ANT3 protein homeostasis regulation remains unclear. We found that prolonged starvation induces cell death by mediating ANT3 deacetylation-dependent pathways through the mitochondrial translocation of SIRT2, which in turn regulates ANT3 protein levels and conformational changes. Specifically, we demonstrated that prolonged starvation promotes the mitochondrial translocation of SIRT2, thereby enhancing its binding to ANT3. This interaction leads to the deacetylation of ANT3 at K96 by SIRT2. Deacetylation of K96 by SIRT2 simultaneously promotes ANT3 conformational changes and the formation of the ANT3-VDAC1 complex. Concurrently, ANT3 also binds more strongly to USP15, leading to enhanced ANT3 deubiquitination and protein stability, which further increases the formation of the ANT3-VDAC1 complex and accelerates the process of cell death. In summary, this study reveals a rarely reported molecular mechanism of SIRT2-mediated acetylation-dependent regulation of programmed cell death.
- 29 September 2026
- Published by Springer Nature in Cell Death Discovery
Open AccessSIRT2-mediated deacetylation of ANT3 at Lys96 promotes cell death
ANT3 is a key molecule that constitutes the mitochondrial permeability transition pore (mPTP) and mediates cell death. Disruption or conformational changes in ANT3 protein homeostasis can trigger cell death. However, the molecular mechanism of ANT3 protein homeostasis regulation remains unclear. We found that prolonged starvation induces cell death by mediating ANT3 deacetylation-dependent pathways through the mitochondrial translocation of SIRT2, which in turn regulates ANT3 protein levels and conformational changes. Specifically, we demonstrated that prolonged starvation promotes the mitochondrial translocation of SIRT2, thereby enhancing its binding to ANT3. This interaction leads to the deacetylation of ANT3 at K96 by SIRT2. Deacetylation of K96 by SIRT2 simultaneously promotes ANT3 conformational changes and the formation of the ANT3-VDAC1 complex. Concurrently, ANT3 also binds more strongly to USP15, leading to enhanced ANT3 deubiquitination and protein stability, which further increases the formation of the ANT3-VDAC1 complex and accelerates the process of cell death. In summary, this study reveals a rarely reported molecular mechanism of SIRT2-mediated acetylation-dependent regulation of programmed cell death.
- Open Access
- 15 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Phosphorylation of OTUB1 promotes autophagy initiation under starvation
- 15 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessPhosphorylation of OTUB1 promotes autophagy initiation under starvation
- Open Access
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
Comparison of the CDUPRT distribution, anti-tumor capacity and toxicity of mCDUPRT versus circCDUPRT after intravenous or intratumoral administration.
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
Comparison of the CDUPRT distribution, anti-tumor capacity and toxicity of mCDUPRT versus circCDUPRT after intravenous or intratumoral administration.
- Open Access
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
The chemical structure of the 5-Flucytosine (5-FC), 5-Fluorouraci (5-FU) and 5-Fluoro-deoxyuridine monophosphate (5-FUMP).
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
The chemical structure of the 5-Flucytosine (5-FC), 5-Fluorouraci (5-FU) and 5-Fluoro-deoxyuridine monophosphate (5-FUMP).
- Open Access
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
The sequences of circGFP, circCDUPRT, circIL, and circScram
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
The sequences of circGFP, circCDUPRT, circIL, and circScram
- Open Access
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
Comparison of mCDUPRT and circCDUPRT in vitro anti-tumor ability, protein translation ability and prodrug transformation ability under different concentrations and times.
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
Comparison of mCDUPRT and circCDUPRT in vitro anti-tumor ability, protein translation ability and prodrug transformation ability under different concentrations and times.
- Open Access
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Data from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
Gene-directed enzyme prodrug therapy represents a promising antitumor strategy owing to its low systemic toxicity. However, clinical translation has been hindered by challenges in suicide gene delivery. Artificially engineered circular RNA (circRNA) demonstrates exceptional potential for gene delivery when combined with lipid nanoparticle technology, exhibiting high stability, prolonged protein-coding capacity, and cost-effective production. We developed an in vitro synthesized circRNA encoding the cytosine deaminase–uracil phosphoribosyltransferase (circCDUPRT). Upon intratumoral administration, circCDUPRT achieved sustained intratumoral expression with minimal systemic toxicity. The combination of circCDUPRT and prodrug 5-fluorocytosine showed significant antitumor efficacy in both in vitro and in vivo tumor models. In advanced melanoma models, combining circCDUPRT/5-fluorocytosine with IL-15–expressing circRNA potently enhanced the expansion and activation of CD8+ T and NK cells. Collectively, these findings establish the synthetic circRNA platform as a cost-effective, high-efficiency delivery system for gene-directed enzyme prodrug therapy and immunotherapy applications.
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
Gene-directed enzyme prodrug therapy represents a promising antitumor strategy owing to its low systemic toxicity. However, clinical translation has been hindered by challenges in suicide gene delivery. Artificially engineered circular RNA (circRNA) demonstrates exceptional potential for gene delivery when combined with lipid nanoparticle technology, exhibiting high stability, prolonged protein-coding capacity, and cost-effective production. We developed an in vitro synthesized circRNA encoding the cytosine deaminase–uracil phosphoribosyltransferase (circCDUPRT). Upon intratumoral administration, circCDUPRT achieved sustained intratumoral expression with minimal systemic toxicity. The combination of circCDUPRT and prodrug 5-fluorocytosine showed significant antitumor efficacy in both in vitro and in vivo tumor models. In advanced melanoma models, combining circCDUPRT/5-fluorocytosine with IL-15–expressing circRNA potently enhanced the expansion and activation of CD8+ T and NK cells. Collectively, these findings establish the synthetic circRNA platform as a cost-effective, high-efficiency delivery system for gene-directed enzyme prodrug therapy and immunotherapy applications.
- Open Access
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
Validation of the tumor-targeting capacity and low toxicity of circCDUPRT on a 4T1 tumor-bearing mouse model.
- 4 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Intratumoral Administration of Engineered circRNAs Encoding Cytosine Deaminase–Uracil Phosphoribosyltransferase and IL-15 Elicits Superior Antitumor Efficacy
Validation of the tumor-targeting capacity and low toxicity of circCDUPRT on a 4T1 tumor-bearing mouse model.
- 13 November 2025
- Published by Springer Nature in Oncogene
- Vol. 44 (48) , 4727-4746
Chaperone-mediated autophagy controlling VEGFR1 degradation contributes cross talk between breast cancer cells and endothelial cells triggering tumorigenesis via the VEGF-VEGFR2 axis
The reciprocal cross talk between breast cancer cells and the endothelial cells, through the secretion of growth factors, plays a vital role in angiogenesis and tumorigenesis. We previously demonstrated that chaperone-mediated autophagy (CMA) promotes breast cancer tumorigenesis. However, whether the cross talk between cancer cells with endothelial cells plays a role in CMA-mediated breast tumor tumorigenesis is unknown. We discovered that the conditioned medium (CM) from breast cancer cells with high CMA activity promoted tube formation of endothelial cells (ECs) via the VEGF-VEGFR2 axis. High CMA activity directly promoted angiogenesis of endothelial cells via the VEGF-VEGFR2 axis. The CM from ECs with high level CMA activity accelerated survival and migration of breast cancer cells in vitro via the VEGF-VEGFR2 axis. Co-injection of breast cancer cells mixed with ECs with high level CMA activity trigged angiogenesis and accelerated tumorigenesis in vivo. CMA activity and microvessel numbers were positively correlated with VEGF-VEGFR2 axis between paired breast tumor and normal adjacent tissue. CMA, a highly selective lysosome-dependent degradation process directly degrades VEGFR1 which can serve as a competitively regulatory factor for VEGFR2 regulating its signaling. Our study showed that the cross talk between breast cancer cells and endothelial cells induced by CMA -mediated degradation of VEGFR1 triggers angiogenesis and tumorigenesis via the VEGF-VEGFR2 axis.
- 13 November 2025
- Published by Springer Nature in Oncogene
- Vol. 44 (48) , 4727-4746
Chaperone-mediated autophagy controlling VEGFR1 degradation contributes cross talk between breast cancer cells and endothelial cells triggering tumorigenesis via the VEGF-VEGFR2 axis
The reciprocal cross talk between breast cancer cells and the endothelial cells, through the secretion of growth factors, plays a vital role in angiogenesis and tumorigenesis. We previously demonstrated that chaperone-mediated autophagy (CMA) promotes breast cancer tumorigenesis. However, whether the cross talk between cancer cells with endothelial cells plays a role in CMA-mediated breast tumor tumorigenesis is unknown. We discovered that the conditioned medium (CM) from breast cancer cells with high CMA activity promoted tube formation of endothelial cells (ECs) via the VEGF-VEGFR2 axis. High CMA activity directly promoted angiogenesis of endothelial cells via the VEGF-VEGFR2 axis. The CM from ECs with high level CMA activity accelerated survival and migration of breast cancer cells in vitro via the VEGF-VEGFR2 axis. Co-injection of breast cancer cells mixed with ECs with high level CMA activity trigged angiogenesis and accelerated tumorigenesis in vivo. CMA activity and microvessel numbers were positively correlated with VEGF-VEGFR2 axis between paired breast tumor and normal adjacent tissue. CMA, a highly selective lysosome-dependent degradation process directly degrades VEGFR1 which can serve as a competitively regulatory factor for VEGFR2 regulating its signaling. Our study showed that the cross talk between breast cancer cells and endothelial cells induced by CMA -mediated degradation of VEGFR1 triggers angiogenesis and tumorigenesis via the VEGF-VEGFR2 axis.
- Open Access
- 11 October 2025
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (10) , 102413
Local delivery of IL-15 and anti-PD-L1 nanobody by in vitro-transcribed circILNb elicits superior antitumor immunity in cold tumors
- 11 October 2025
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (10) , 102413
Open AccessLocal delivery of IL-15 and anti-PD-L1 nanobody by in vitro-transcribed circILNb elicits superior antitumor immunity in cold tumors